Skip to main content
Elazer R Edelman on Muck Rack

Elazer R Edelman

As seen in: MSN, Nature, Wiley Online Library, Fortune, Gut Journal, PNAS, VentureBeat, Science Magazine, Cell Press, NewsBreak and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Elazer R

Contact Elazer R, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Sprayable Hydrogel Sealant for Gastrointestinal Wound Shielding

|
By Gonzalo Muñoz Taboada, Daniel Dahis, Elazer R Edelman, Natalie Artzi
| Wiley Online Library Verified
Supporting Information Filename Description adma202311798-sup-0001-SuppMat.pdf764.5 KB Supplementary information adma202311798-sup-0002-VideoS1.mp434.8 MB Supplementary information adma202311798-sup-0003-VideoS2.mp421.8 MB Supplementary information adma202311798-sup-0004-VideoS3.mp429.6 MB Supplementary information adma202311798-sup-0005-VideoS4.mp432.4 MB Supplementary information
Open in Who Shared Issue with article?

How important is explainability? Applying clinical trial principles to AI safety testing

|
By Caroline O’Brien, Elazer R Edelman
| VentureBeat Verified
Join leaders in San Francisco on January 10 for an exclusive night of networking, insights, and conversation. Request an invite here. The use of AI in consumer-facing businesses is on the rise — as is the concern for how best to govern the technology over the long-term. Pressure to better govern AI is only growing with the Biden administration’s recent executive order that mandated new measurement protocols for the development and use of advanced AI systems.
Open in Who Shared View Duplicates (6) Issue with article?

Interventional therapies for pulmonary embolism - Nature Reviews Cardiology

|
By Lucas Lauder, Elazer R Edelman
| Nature Verified
Abstract Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most frequent cause of cardiovascular death. The clinical presentation of PE is variable, and choosing the appropriate treatment for individual patients can be challenging.
Open in Who Shared Issue with article?
See all 18 licensed articles (19 Total)